๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS ยท Delayed Price ยท Currency is USD
0.32472
+0.00082 (0.25%)
At close: Nov 20, 2026

Elite Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
144.77148.8784.0456.6334.1632.26
Revenue Growth
17.80%77.13%48.42%65.79%5.87%27.11%
Gross Profit
63.2275.0240.0926.3616.5914.8
Operating Income
37.549.9621.210.793.975.07
Net Income
60.2844.87-4.3120.113.568.9
Earnings Per Share
0.030.03-0.000.020.000.01
EPS Growth
128.93%--537.54%-57.99%81.05%

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
34.8629.811.327.117.838.54
Total Debt
5.185.8210.9111.743.892.78
Net Cash (Debt)
29.6823.980.4-4.633.945.75
Net Cash Growth
46.08%5888.11%---31.44%606.63%
Net Cash Per Share
0.030.020.00-0.000.000.01

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
10.8623.757.46-3.243.346.51
Capital Expenditures
-2.15-0.93-1.63-0.81-5.74-0.5
Free Cash Flow
8.7222.825.83-4.04-2.46.01
Free Cash Flow Growth
-59.75%291.43%---109.85%

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
43.67%50.40%47.70%46.55%48.58%45.86%
Operating Margin
25.90%33.56%25.23%19.05%11.62%15.72%
Pretax Margin
47.76%38.16%-0.06%0.82%11.67%22.20%
Profit Margin
41.64%30.14%-5.13%35.51%10.43%27.58%
FCF Margin
6.02%15.33%6.94%-7.14%-7.02%18.63%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
10.248.64-7.818.263.97
P/FCF Ratio
40.1316.9979.70--5.88
PS Ratio
2.422.615.532.770.861.10